Wells Fargo
MJN

Wells Fargo’s Mead Johnson Nutrition Company MJN Stock Holding History

Wells Fargo’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-69,900
Closed -$628K – 6626
2016
Q3 		$628K Buy
+69,900
New +$5.96M ﹤0.01% 3818

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.24B AUM 18.68% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Wells Fargo's MJN Position: Q2 2017 in Review

Wells Fargo sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 472,164 shares — an estimated $42.1M sold.

Wells Fargo first reported a position in MJN in Q2 2013 and held it in 16 quarters. The position peaked at $70.5M in Q4 2014. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Wells Fargo reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Wells Fargo sold 472,164 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $42.1M.
  • Wells Fargo first reported a position in Mead Johnson Nutrition Company in Q2 2013 and held it in 16 quarters.
  • Wells Fargo's Mead Johnson Nutrition Company position peaked at $70.5M in Q4 2014.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Wells Fargo's 13F filing for Q2 2017, filed 10 Aug 2017.